Global Lancet and Pen Needles Market Size By Type (17/18G, 21G), By Application (Clinics, Hospitals), By Region, And Segment Forecasts, 2023 to 2032

The Global Lancet and Pen Needles Market was valued at USD 3.1 billion in 2023 and is expected to reach USD 5.4 billion by 2031, growing at a CAGR of 7.3% during the forecast period (2023–2031). The rising prevalence of diabetes and other chronic conditions requiring insulin administration, coupled with the increasing adoption of self-administration devices, is significantly driving market growth. Enhanced awareness of diabetes management, innovations in needle safety, and demand for minimally invasive and user-friendly devices further accelerate adoption. Moreover, technological advancements such as ultra-fine needles and safety-engineered lancets are contributing to user compliance and market expansion globally.

Drivers:

Rising Incidence of Diabetes:

The global diabetes burden is climbing, with over 530 million adults affected in 2023. The increasing demand for insulin and regular glucose monitoring is propelling the use of lancets and pen needles, especially among the aging population.

Growing Trend of Home Healthcare:

The shift from institutional to home-based care is encouraging patients to use pen needles and lancets for self-monitoring of blood glucose and self-injection of insulin. This trend is supported by the convenience, privacy, and cost-effectiveness of home treatment.

Product Innovation and Miniaturization:

Pen needles are becoming shorter, thinner, and less painful, improving comfort for users. Manufacturers are focusing on safety features like retractable or shielded needles to reduce needlestick injuries, enhancing acceptance in both home and clinical settings.

Restraints:

Needlestick Injury Concerns:

Despite innovations, improper handling of lancets and pen needles can lead to accidental needlestick injuries, raising concerns among users and healthcare workers and potentially limiting widespread usage.

Environmental Impact and Waste Disposal Issues:

Used needles and lancets contribute to biohazardous waste. The lack of consistent global regulations for the safe disposal of sharps can act as a restraint, especially in developing countries.

Opportunity:

Increased Adoption in Emerging Markets:

Rising healthcare access, awareness campaigns, and growing diabetic populations in Asia-Pacific, Latin America, and parts of Africa create significant growth opportunities. Governments and NGOs are working to improve diagnostic and treatment capabilities in these regions.

Integration with Smart Healthcare Devices:

The convergence of lancets and pen needles with connected diabetes management tools offers tremendous potential. Innovations such as smart insulin pens and app-integrated glucose monitoring systems are paving the way for personalized and efficient chronic disease management.

Market by System Type Insights:

By system type, Standard Pen Needles held the largest market share in 2023, owing to their broad usage across various insulin pens and affordability. However, Safety Pen Needles are expected to witness the fastest growth through 2031 due to increasing concerns regarding needlestick injuries and regulatory pressure to adopt safer alternatives.

Market by End-use Insights:

Hospitals and Clinics dominated the end-use segment in 2023 due to the high patient inflow and frequent use of pen needles and lancets for both inpatient and outpatient care. However, the Homecare segment is projected to grow rapidly during the forecast period, driven by the rising trend of self-care and technological ease of use.

Market by Regional Insights:

North America led the global lancet and pen needles market in 2023, supported by well-established healthcare systems, favorable reimbursement policies, and high awareness among patients. Meanwhile, Asia-Pacific is expected to register the highest CAGR, attributed to increasing healthcare infrastructure investments, growing diabetic populations, and government-led awareness programs in countries like India and China.

Competitive Scenario:

Key players in the Global Lancet and Pen Needles Market include Becton, Dickinson and Company, Novo Nordisk A/S, Terumo Corporation, Ypsomed Holding AG, Owen Mumford Ltd, B. Braun Melsungen AG, HTL-Strefa S.A., Allison Medical, Inc., and Arkray, Inc. Companies are focusing on strategic collaborations, geographical expansion, and R&D investments in safety-engineered and ergonomic devices. For instance:

In 2023, BD launched a new pen needle designed for reduced injection force, improving ease-of-use for elderly patients.

In 2024, Novo Nordisk announced a partnership with digital diabetes platforms to integrate its smart insulin pen with mobile apps for better diabetes management.

Ypsomed expanded its manufacturing footprint in India in 2025 to cater to the growing demand in Asia-Pacific.

Scope of Work – Global Lancet and Pen Needles Market

Report Metric Details

Market Size (2023) USD 3.1 billion

Projected Market Size (2031) USD 5.4 billion

CAGR (2023–2031) 7.3%

Market Segments By System Type (Standard, Safety), By End-use (Hospitals & Clinics, Homecare), By Region

Growth Drivers Rising diabetes prevalence, Technological innovation, Homecare trend

Opportunities Emerging markets, Smart device integration

Key Market Developments:

June 2023: BD introduced its next-generation pen needle with an enhanced lubricated coating for smoother penetration and reduced pain.

January 2024: Terumo announced FDA approval for its ultra-fine lancet series with micro-needle technology.

March 2025: Owen Mumford launched a biodegradable pen needle prototype, addressing environmental concerns and expanding sustainable product lines.

FAQs:

1. What is the current market size of the Global Lancet and Pen Needles Market?

The market was valued at USD 3.1 billion in 2023.

2. What is the major growth driver of the Global Lancet and Pen Needles Market?

The rising prevalence of diabetes and increasing demand for self-administration devices.

3. Which is the largest region during the forecast period in the Global Lancet and Pen Needles Market?

North America holds the largest market share due to high awareness and advanced healthcare infrastructure.

4. Which segment accounted for the largest market share in Global Lancet and Pen Needles Market?

The Standard Pen Needles segment led in 2023, but Safety Pen Needles are growing rapidly.

5. Who are the key market players in the Global Lancet and Pen Needles Market?

BD, Novo Nordisk, Terumo, Ypsomed, Owen Mumford, B. Braun, HTL-Strefa, and others.

Would you like a visual chart or infographic to accompany this report summary?